SecBot SecBot
SECBOTREPLAY Home › Report › BCRX

BCRX · Two BioCryst insiders sold a total of $697K in open-market sales within…

BIOCRYST PHARMACEUTICALS INC · CLUSTER filed May 19, 2026 at 16:07 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed May 19, 2026 at 16:07 ET

Two BioCryst insiders sold a total of $697K in open-market sales within a week of Q1 2026 earnings. The CLO exercised 62,500 options at $5.04 and immediately sold the shares at $9.54 for a $596K profit; a director sold 11,180 shares for $100K. The cluster value is ~0.03% of the $2.3B market cap, well below the 0.1% materiality threshold, and the CLO's sale is a routine cashless exercise pattern. The earnings filing showed in-line ORLADEYO revenue and maintained guidance, providing no bearish catalyst.

  • Chief Legal Officer Barnes exercised 62,500 options at $5.04 and sold the shares at $9.54 for $596K on 2026-05-13
  • Director McKee sold 11,180 shares at $8.97 for $100K on 2026-05-18
  • Total insider sales of $697K represent ~0.03% of BCRX's $2.3B market cap
  • Q1 2026 ORLADEYO revenue of $148.3M (+11% YoY) was in line with maintained FY2026 guidance of $625-645M

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access